Paul Van Slyke

1.2k total citations
32 papers, 966 citations indexed

About

Paul Van Slyke is a scholar working on Molecular Biology, Immunology and Cardiology and Cardiovascular Medicine. According to data from OpenAlex, Paul Van Slyke has authored 32 papers receiving a total of 966 indexed citations (citations by other indexed papers that have themselves been cited), including 19 papers in Molecular Biology, 9 papers in Immunology and 8 papers in Cardiology and Cardiovascular Medicine. Recurrent topics in Paul Van Slyke's work include Angiogenesis and VEGF in Cancer (14 papers), Lipid metabolism and disorders (7 papers) and Traumatic Brain Injury and Neurovascular Disturbances (5 papers). Paul Van Slyke is often cited by papers focused on Angiogenesis and VEGF in Cancer (14 papers), Lipid metabolism and disorders (7 papers) and Traumatic Brain Injury and Neurovascular Disturbances (5 papers). Paul Van Slyke collaborates with scholars based in Canada, Germany and United States. Paul Van Slyke's co-authors include Daniel Dumont, Philipp Kümpers, Sascha David, Samir M. Parikh, Nicole L. Ward, Dan Dumont, Nelli Shushakova, Jennifer Alami, Robert S. Kerbel and Harold Kim and has published in prestigious journals such as Journal of Biological Chemistry, Molecular and Cellular Biology and Cancer Research.

In The Last Decade

Paul Van Slyke

32 papers receiving 944 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Paul Van Slyke Canada	19	435	181	173	161	148	32	966
Chaoyong Zhu Sweden	17	416 1.0×	210 1.2×	155 0.9×	124 0.8×	130 0.9×	21	1.2k
Goichi Honda Japan	17	418 1.0×	169 0.9×	252 1.5×	260 1.6×	87 0.6×	38	1.5k
Clemens Feistritzer Austria	19	327 0.8×	119 0.7×	189 1.1×	51 0.3×	139 0.9×	51	976
Anne Zufferey Switzerland	16	317 0.7×	63 0.3×	271 1.6×	154 1.0×	103 0.7×	24	1.3k
Roxane Darbousset France	11	314 0.7×	126 0.7×	318 1.8×	166 1.0×	323 2.2×	12	1.2k
Rashmi Sood United States	15	373 0.9×	178 1.0×	191 1.1×	165 1.0×	87 0.6×	24	1.3k
Lauren Clancy United States	8	370 0.9×	183 1.0×	337 1.9×	148 0.9×	238 1.6×	13	1.2k
Matthias Herrmann Germany	9	464 1.1×	108 0.6×	237 1.4×	223 1.4×	184 1.2×	20	1.0k
Laurent Burnier Switzerland	17	475 1.1×	72 0.4×	394 2.3×	163 1.0×	68 0.5×	28	1.3k
B. Hugel France	12	549 1.3×	77 0.4×	233 1.3×	163 1.0×	72 0.5×	14	1.0k

Countries citing papers authored by Paul Van Slyke

Since Specialization

Citations

This map shows the geographic impact of Paul Van Slyke's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Paul Van Slyke with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Paul Van Slyke more than expected).

Fields of papers citing papers by Paul Van Slyke

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Paul Van Slyke. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Paul Van Slyke. The network helps show where Paul Van Slyke may publish in the future.

Co-authorship network of co-authors of Paul Van Slyke

This figure shows the co-authorship network connecting the top 25 collaborators of Paul Van Slyke. A scholar is included among the top collaborators of Paul Van Slyke based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Paul Van Slyke. Paul Van Slyke is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Gutbier, Birgitt, Olivia Kershaw, Geraldine Nouailles, et al.. (2022). Adjunctive therapy with the Tie2 agonist Vasculotide reduces pulmonary permeability in Streptococcus pneumoniae infected and mechanically ventilated mice. Scientific Reports. 12(1). 15531–15531. 7 indexed citations

Leeuwen, Anoek L. I. van, Nicole Dekker, Paul Van Slyke, et al.. (2021). The effect of targeting Tie2 on hemorrhagic shock-induced renal perfusion disturbances in rats. Intensive Care Medicine Experimental. 9(1). 23–23. 5 indexed citations

Rovas, Alexandros, Kristina Kusche‐Vihrog, Paul Van Slyke, et al.. (2019). Tie2 Activation Promotes Protection and Reconstitution of the Endothelial Glycocalyx in Human Sepsis. Thrombosis and Haemostasis. 119(11). 1827–1838. 39 indexed citations

Slyke, Paul Van, et al.. (2018). Tie2 signalling through Erk1/2 regulates TLR4 driven inflammation. Cellular Signalling. 51. 211–221. 3 indexed citations

Dekker, Nicole, Matijs van Meurs, Anoek L. I. van Leeuwen, et al.. (2018). Vasculotide, an angiopoietin-1 mimetic, reduces pulmonary vascular leakage and preserves microcirculatory perfusion during cardiopulmonary bypass in rats. British Journal of Anaesthesia. 121(5). 1041–1051. 32 indexed citations

Meurs, Matijs van, Anoek L. I. van Leeuwen, Paul Van Slyke, et al.. (2017). Vasculotide, an Angiopoietin-1 Mimetic, Restores Microcirculatory Perfusion and Microvascular Leakage and Decreases Fluid Resuscitation Requirements in Hemorrhagic Shock. Anesthesiology. 128(2). 361–374. 32 indexed citations

Stypmann, Jörg, Paul Van Slyke, Daniel Dumont, et al.. (2016). The Synthetic Tie2 Agonist Peptide Vasculotide Protects Renal Vascular Barrier Function In Experimental Acute Kidney Injury. Scientific Reports. 6(1). 22111–22111. 37 indexed citations

Gutbier, Birgitt, Xiaoqin Jiang, Norbert Weißmann, et al.. (2016). The Tie2-Agonist Vasculotide Protects Lungs from Pneumonia-induced Barrier Disruption. Pneumologie. 70(S 01). 1 indexed citations

Sugiyama, Michael G., Susan Armstrong, Changsen Wang, et al.. (2015). The Tie2-agonist Vasculotide rescues mice from influenza virus infection. Scientific Reports. 5(1). 11030–11030. 52 indexed citations

10.

Yohan, Darren, Lee Chin, Anthony Kim, et al.. (2014). Vasculotide, an Angiopoietin-1 mimetic, reduces acute skin ionizing radiation damage in a preclinical mouse model. BMC Cancer. 14(1). 614–614. 21 indexed citations

11.

Aviv, Richard I., Thien Huynh, Yongwei Huang, et al.. (2014). An In Vivo, MRI-Integrated Real-Time Model of Active Contrast Extravasation in Acute Intracerebral Hemorrhage. American Journal of Neuroradiology. 35(9). 1693–1699. 18 indexed citations

12.

David, Sascha, Philipp Kümpers, Paul Van Slyke, & Samir M. Parikh. (2013). Mending Leaky Blood Vessels: The Angiopoietin-Tie2 Pathway in Sepsis. Journal of Pharmacology and Experimental Therapeutics. 345(1). 2–6. 62 indexed citations

13.

Kümpers, Philipp, Faikah Gueler, Sascha David, et al.. (2011). The synthetic Tie2 agonist peptide vasculotide protects against vascular leakage and reduces mortality in murine abdominal sepsis. Critical Care. 15(5). R261–R261. 107 indexed citations

14.

Hanna, George P., Eric C. Yang, Paul Van Slyke, et al.. (2010). Differential proteomic analysis of lymphatic, venous, and arterial endothelial cells extracted from bovine mesenteric vessels. PROTEOMICS. 10(8). 1658–1672. 13 indexed citations

15.

Slyke, Paul Van, et al.. (2009). Angiopoietin-1-induced ubiquitylation of Tie2 by c-Cbl is required for internalization and degradation. Biochemical Journal. 423(3). 375–380. 14 indexed citations

16.

Ebos, John M.L., Christina R. Lee, Elena Bogdanovic, et al.. (2008). Vascular Endothelial Growth Factor–Mediated Decrease in Plasma Soluble Vascular Endothelial Growth Factor Receptor-2 Levels as a Surrogate Biomarker for Tumor Growth. Cancer Research. 68(2). 521–529. 95 indexed citations

17.

Slyke, Paul Van, Jennifer Alami, Daniel Martín, et al.. (2008). Acceleration of Diabetic Wound Healing by an Angiopoietin Peptide Mimetic. Tissue Engineering Part A. 15(6). 1269–1280. 49 indexed citations

18.

Slyke, Paul Van, et al.. (2006). Chronic systemic delivery of angiopoietin-2 reveals a possible independent angiogenic effect. American Journal of Physiology-Heart and Circulatory Physiology. 291(2). H948–H956. 19 indexed citations

19.

Voskas, Daniel, Nina Jones, Paul Van Slyke, et al.. (2005). A Cyclosporine-Sensitive Psoriasis-Like Disease Produced in Tie2 Transgenic Mice. American Journal Of Pathology. 166(3). 843–855. 67 indexed citations

20.

Slyke, Paul Van, Mariano Loza‐Coll, Zubin Master, et al.. (2005). Dok-R Mediates Attenuation of Epidermal Growth Factor-Dependent Mitogen-Activated Protein Kinase and Akt Activation through Processive Recruitment of c-Src and Csk. Molecular and Cellular Biology. 25(9). 3831–3841. 29 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact